CPT code 28046 denotes an extensive surgical excision of a soft-tissue tumor or mass in the foot or toe when malignancy is suspected, with the tumor and margins measuring under 3 cm. The code captures more complex soft-tissue tumor removals in distal lower-extremity sites and is relevant across surgical oncology, orthopedic surgery, and podiatry practices. Nationally, accurate use of this code affects episode-level reporting, claim adjudication, and clinical documentation surrounding suspected malignant soft-tissue lesions.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical scenario represented by the code, common settings where the service is performed, and the typical documentation elements that support appropriate code selection. The publication also summarizes common modifier practices, payer coverage considerations, and related billing guidance where available. Policy updates, utilization benchmarks, and payer-specific coding notes are presented to inform coding accuracy and administrative workflows for clinicians and billing professionals nationwide.